We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSON:LSEPearson PLC Analysis

Data as of 2026-05-22 - not real-time

£1,129.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical momentum remains bullish as the short‑term moving average sits above the medium‑term average, while the price comfortably trades above the identified support level. Relative strength is elevated but not yet in overbought territory, and the MACD histogram shows a slight bearish tilt, suggesting a brief pause before the uptrend resumes. Volume has been tapering, which often precedes a consolidation phase that can set the stage for a modest rally toward the next resistance zone.
Fundamental backdrop is supportive: revenue growth is modest yet steady, with the virtual learning segment delivering standout expansion. Margins are healthy, cash flow generation is robust, and the dividend yield is attractive with a payout ratio comfortably below the sustainability threshold. The discounted cash‑flow model indicates a sizable upside relative to the current market price, reinforcing an undervalued perception. Combined with low systematic risk and a solid balance sheet, the stock presents a compelling case for investors seeking a blend of growth and income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • short‑term moving average above medium‑term average
  • price above support with limited upside near resistance
  • elevated but not overbought RSI

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to intrinsic DCF estimate
  • strong growth in virtual learning driving earnings expansion
  • sustainable dividend with solid cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • secular demand for education and skills development
  • low beta indicating defensive characteristics
  • robust balance sheet and attractive dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin9.37%
P/E Ratio22.1
ROE8.71%
ROA4.73%
Debt/Equity40.51
P/B Ratio2.0
Op. Cash Flow£656.0M
Free Cash Flow£863.8M
Industry P/E17.1

Technical Analysis

TrendBullish
RSI64.0
Support£1,066.29
Resistance£1,153.50
MA 20£1,103.95
MA 50£1,046.20
MA 200£1,026.80
MACDBearish
VolumeDecreasing
Fear & Greed Index91.23

Valuation

Fair Value£1,950.47
Target Price£1,183.00
Upside/Downside4.78%
GradeUndervalued
TypeBlend
Dividend Yield2.23%

Risk Assessment

Beta0.17
Volatility21.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.